Cidara Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CDTX and other ETFs, options, and stocks.

About CDTX

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak.

CEO

Jeffrey L. Stein

CEOJeffrey L. Stein

Employees

Employees38

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

Employees38

CDTX Key Statistics

Market cap

1.07B

Market cap1.07B

Price-Earnings ratio

-1.68

Price-Earnings ratio-1.68

Dividend yield

—

Dividend yield—

Average volume

2.35M

Average volume2.35M

High today

$49.37

High today$49.37

Low today

$46.39

Low today$46.39

Open price

$47.46

Open price$47.46

Volume

411.64K

Volume411.64K

52 Week high

$56.83

52 Week high$56.83

52 Week low

$10.14

52 Week low$10.14

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CDTX. This list is generated using Robinhood data, and it’s not a recommendation.

Cidara Therapeutics

Why Robinhood?

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. Show more

CDTX Key Statistics

Analyst ratings

100%

People also own

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak.